Abstract:Plasmodium vivax infection, when it occurs during pregnancy, has often been associated with serious adverse pregnancy outcomes. However, immunological alterations in pregnancy and their consequences have been little explored. We characterized the humoral immune response in pregnant women exposed to malaria by P . vivax antigens and its association with the maternal inflammatory profile and poor pregnancy outcomes. An observational cohort study in the Brazilian Amazon was conducted between 2013 and 2015. After applying exclusion criteria, 242 mother-child pairs were included in the analysis. Data on maternal infection, gestational outcomes, and inflammatory factors were evaluated in the maternal peripheral plasma. In samples from the first infection, the presence of total IgG and its subclasses in plasma against PvMSP1 19 protein were also quantified. Previous exposure to malaria, observed by anti-total IgG antibodies to the PvMSP1 19 antigen, increased the inflammatory response to infection when the pregnant woman had malaria during pregnancy. IL-6 and IL-10 levels were positively correlated with parasitemia and with total IgG levels; but they were negatively correlated with the gestational age at delivery from Pv -infected woman. In multivariate linear regression analyses, IgG 1, 2 and 4 was negatively and positively associated with cytokines IL-6 and IL-10, respectively, in P . vivax- infection. An association between the humoral immune response and the peripheral inflammatory cytokine profile with the adverse outcomes in malaria in pregnancy by P . vivax was observed. Previous exposure to the parasite can influence the IL-6 and IL-10 response, which is associated with increased parasitemia, reduced maternal weight gain and premature delivery. Plasmodium vivax malaria in pregnancy is also associated with several adverse outcomes, even in low-transmission regions such as South America. However, to our knowledge, no study has previously investigated the link between the humoral immune response due to previous exposure to P . vivax and the immunological profile during pregnancy infection and its association with poor pregnancy outcomes. In this study, after applying exclusion criteria, 242 mother-child pairs were evaluated for different immunological markers of malaria exposure in an endemic area in the Brazilian Amazon. We showed that previous exposure to P . vivax , through the humoral immune response to the PvMSP1 19 antigen, can exacerbate the inflammatory response during gestational malaria and is associated with increased parasitemia, reduced maternal weight gain and premature delivery. These findings help to understand the association between anti-PvMSP1 19 antibodies, considered exposure marker, and the maternal peripheral inflammatory profile throughout pregnancy, bringing important implications for understanding the immunobiology of the disease.

Antibody response to malaria vaccine candidates in pregnant women with Plasmodium falciparum and Schistosoma haematobium infections

Specific antibody responses to Qβ‐displayed Plasmodium falciparum‐derived UB05 and MSP3 proteins in mother–neonate couples

Acquisition of antibodies that block Plasmodium falciparum adhesion to placental receptor chondroitin sulfate A with increasing gravidity in Malian women

Autoantibodies Inhibit Plasmodium Falciparum Growth and Are Associated with Protection from Clinical Malaria

Infections with Plasmodium falciparum during pregnancy affect VAR2CSA DBL-5 domain-specific T cell cytokine responses

Plasmodium Falciparum-Specific IgM B Cells Dominate in Children, Expand with Malaria and Produce Parasite Inhibitory IgM

Longitudinal Analysis of Naturally Acquired PfEMP1 CIDR Domain Variant Antibodies Identifies Associations with Malaria Protection.

Differential expression of plasma proteins in pregnant women exposed to malaria

Acquisition of anti-phosphatidylserine IgM and IgG antibodies by infants and their mothers over time in Uganda

The prevalence of molecular markers of resistance to sulfadoxine-pyrimethamine among pregnant women at first antenatal clinic attendance and delivery in the forest-savannah area of Ghana.

PREVALENCE OF PLACENTAL INFECTION WITH PLASMODIUM FALCIPARUM DETECTED BY POLYMERASE CHAIN REACTION AND ASSOCIATED RISK FACTORS IN WOMEN AFTER DELIVERED OUAGADOUGOU (BURKINA FASO)

IgG and IgM responses to the Plasmodium falciparum asexual stage antigens reflect respectively protection against malaria during pregnancy and infanthood

Prevalence of Malaria Infection in Pregnant Women Attending Antenatal Clinics in Southern Senegal

First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated Malaria

Association of the humoral immune response with the inflammatory profile in Plasmodium vivax infections in pregnant women

Intestinal barrier disruption with Plasmodium falciparum infection in pregnancy and risk of preterm birth: a cohort study

Anti-phosphatidylserine antibody levels are low in multigravid pregnant women in a malaria-endemic area in Nigeria, and do not correlate with anti-VAR2CSA antibodies

Antibodies to PfEMP1 and Variant Surface Antigens: Protection after Controlled Human Malaria Infection in Semi-immune Kenyan Adults

Immunoglobulin G (IgG) specific responses to recombinant Qβ displayed MSP3 and UB05 in plasma of asymptomatic Plasmodium falciparum-infected children living in two different agro-ecological settings of Cameroon

Impact of malaria and hepatitis B co-infection on clinical and cytokine profiles among pregnant women

Reduced Placental Transfer of Antibodies Against a Wide Range of Microbial and Vaccine Antigens in HIV-Infected Women in Mozambique